Jiangsu Nhwa Pharmaceutical Co Ltd (002262)

Shenzhen
Currency in CNY
22.60
-0.03(-0.13%)
Closed
002262 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
22.3122.93
52 wk Range
21.1329.98
Key Statistics
Edit
Bid/Ask
22.61 / 22.61
Prev. Close
22.63
Open
22.68
Day's Range
22.31-22.93
52 wk Range
21.13-29.98
Volume
15.78M
Average Volume (3m)
7.79M
1-Year Change
-13.47%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002262 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
32.04
Upside
+41.79%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
Show more

Jiangsu Nhwa Pharmaceutical Co Ltd Company Profile

Jiangsu Nhwa Pharmaceutical Co., LTD engages in production, marketing, and services related to central nervous system drugs in China. It’s product portfolio includes Duloxetine Hcl, Risperidone, Ziprasidone Hcl, Etomidate Fat Emulsion, Gabapentin, Zaleplon, etc.; and Iptakalim, an anti-hypertension drug. The company’s products are used for treatment of anesthesiology, psychiatry and neurology, as well as APIs. Jiangsu Nhwa Pharmaceutical Co., LTD was founded in 1978 and is headquartered in Xuzhou, China.

Employees
5394
Market
China

Compare 002262 to Peers and Sector

Metrics to compare
002262
Peers
Sector
Relationship
P/E Ratio
19.6x29.3x−0.6x
PEG Ratio
1.54−0.400.00
Price/Book
3.2x2.4x2.6x
Price / LTM Sales
4.2x3.8x3.1x
Upside (Analyst Target)
37.0%42.1%48.8%
Fair Value Upside
Unlock11.6%7.5%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 32.04
(+41.79% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.16
Dividend Yield
1.41%
Industry Median 1.40%
Annualized payout
0.3200
Paid annually
5-Years Growth
+39.77%
Growth Streak

Earnings

Latest Release
Oct 26, 2024
EPS / Forecast
0.40 / 0.41
Revenue / Forecast
1.38B / 1.38B
EPS Revisions
Last 90 days

FAQ

What Is the Nhwa Pharma A (002262) Stock Price Today?

The Nhwa Pharma A stock price today is 22.60

What Stock Exchange Does Nhwa Pharma A Trade On?

Nhwa Pharma A is listed and trades on the Shenzhen stock exchange.

What Is the Stock Symbol for Nhwa Pharma A?

The stock symbol for Nhwa Pharma A is "002262."

Does Nhwa Pharma A Pay Dividends? What’s The Current Dividend Yield?

The Nhwa Pharma A dividend yield is 1.41%.

What Is the Nhwa Pharma A Market Cap?

As of today, Nhwa Pharma A market cap is 23.00B.

What is Nhwa Pharma A Earnings Per Share?

The Nhwa Pharma A EPS is 1.16.

What Is the Next Nhwa Pharma A Earnings Date?

Nhwa Pharma A will release its next earnings report on Mar 28, 2025.

From a Technical Analysis Perspective, Is 002262 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.